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ABSTRACT 
 
 
 
Effects of Aging and Exercise Training on the Mechanisms of Angiotensin II-Induced 
Vasoconstriction in Rat Skeletal Muscle Arterioles. (December 2006) 
Yoonjung Park, B.A., Seoul National University; 
M.S., Seoul National University; 
M.A., The University of Texas at Austin 
Chair of Advisory Committee: Dr. Robert B. Armstrong 
 
 
Aging is associated with increases in regional and systemic vascular resistance 
and impaired ability to increase blood flow to active muscles during exercise. Aging 
enhances vasoconstrictor responsiveness in both humans and animals, and an increase in 
Angiotensin II-induced vasoconstriction is one possible mechanism for old age-
associated increase in muscle vascular resistance. The purpose of this study was to 
determine 1) whether aging alters Ang II-induced vasoconstriction, 2) whether exercise 
training attenuates the age-associated alteration in Ang II-mediated vasoconstriction, and 
3) the mechanism(s) through which aging and exercise training alter Ang II-induced 
vasoconstriction in rat skeletal muscle arterioles. Male Fischer 344 rats were assigned to 
4 groups: Young sedentary (YS; 4 months), old sedentary (OS; 24 months), young 
trained (YT) and old trained (OT). Exercise-trained groups performed treadmill 
exercises for 60 min/day at 15 m/min, on a 15º incline for 5 days/week for 10-12 weeks.  
First-order (1A) arterioles were isolated from soleus and gastrocnemius muscles for in 
 iv
vitro experimentation. Intraluminal diameter changes were determined in response to the 
cumulative addition of Ang II (3×10-11 - 3×10-5 M). Ang II dose responses were then 
determined following the removal of endothelium and treatment with NG-nitro-L-
arginine methyl ester (L-NAME, 10-5 M), a nitric oxide synthase (NOS) inhibitor. Ang 
II-induced vasoconstriction was augmented in the aged skeletal muscle arterioles, both 
in soleus and gastrocnemius muscles, and age-associated increases in Ang II-induced 
vasoconstriction were abolished with the removal of endothelium and with L-NAME. 
Exercise training ameliorated the age-induced increase in Ang II-vasoconstriction, and 
this alteration was eliminated by the removal of endothelium and with NOS inhibition. 
These findings suggest that aging enhances Ang II-induced vasoconstrictor responses in 
the arterioles from both soleus, high oxidative, and white portion of gastrocnemius, low 
oxidative glycolytic muscles, and this age-associated change occurs through an 
endothelium-dependent NOS signaling pathway. These results also demonstrated that 
exercise training can ameliorate the age-associated increase in Ang II vasoconstriction in 
the arterioles from both high oxidative and low oxidative glycolytic muscles through an 
endothelium-mediated NOS mechanism. 
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Aging, exercise training, cardiovascular system, and control of muscle flood 
flow 
By the year 2020, the average life expectancy will be 82.0 years for women and 
74.2 years for men, and by the year 2040, it will increase to 83.1 years for women and 
75.0 years for men (94). The number of the population in the United States over 65 years 
old will rise to 52 million by the year 2020 and to 68 million by the year 2040. This 
rapid growth of the elderly will have an enormous impact on future health care costs (94). 
A characteristic of this population is the high prevalence of cardiovascular diseases, 
which negatively affect both life expectancy and quality of life, and are associated with 
an impaired ability for adaptation to environmental change (91). Epidemiological studies 
have reported that advancing age, genetic factors, diabetes, lipid levels, and sedentary 
lifestyle are all risk factors for cardiovascular disease, such as coronary artery disease, 
hypertension, congestive heart failure, and stroke (39, 57). For example, advancing 
aging is highly correlated with the prevalence of hypertension, incidence of 
atherothrombotic stroke, and incidence of coronary heart disease (57).  
 
_________________ 
This dissertation follows the style and format of American Journal of Physiology-Heart 
and Circulatory Physiology. 
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The old age-related impairment of the cardiovascular system is associated with 
various detrimental changes of cardiovascular structure and function. In terms of 
cardiovascular structure, aging results in increased vascular intimal thickness, vascular 
stiffness, left ventricular wall thickness and left atrial size (37, 55, 57, 76).  Functional 
changes of the cardiovascular system with aging include decreased end diastolic filling 
pressure at rest (68), although systolic function is not significantly altered with aging, 
which preserves ejection fraction and stroke volume (90). Also, cardiac responsiveness 
to β-adrenergic stimuli is decreased with aging, confirming that increases in heart rate 
and myocardial contractility induced by catecholamines or exercise are diminished in 
elderly people and peak cardiac output at maximal exercise is consequently reduced with 
aging (32, 56). 
One of the key interventions that is able to prevent and reduce the risk of 
cardiovascular disease is long term regular physical activity. The benefits of chronic 
physical activity have been reported both in healthy subjects and old patients (12). 
However, aging itself limits elderly individuals to continue a physically active life style 
due to a significantly reduced exercise capacity and maximal aerobic capacity (41, 78). 
This decline in exercise capacity is in part due to an attenuated ability to increase blood 
flow to working muscle during exercise, as well as a diminished ability to elevate 
cardiac output during exercise (63). It has been reported that skeletal muscle perfusion 
during muscle stimulation and exercise is lower in old animals (50, 75) and humans (5, 
60, 64, 82, 84, 86, 106), although skeletal muscle blood flow is not altered with aging 
during rest (18, 41, 111). Irion et al. (50) reported that blood flow is significantly lower 
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in aged rats undergoing intermittent tetanic contractions compared to younger animals.  
Likewise, Musch et al. (75) reported that muscle blood flow in conscious exercising rats 
was reduced with advanced age to highly oxidative muscle, but was increased with aging 
to low oxidative muscle although blood flow to total hindlimb muscles was not different 
between young and old rats during exercise. Human data also indicate that leg muscle 
blood flow is lower with advanced age during submaximal exercise in sedentary men (5, 
82) and women (84) and endurance-trained men (86). For example, Proctor et al. (86) 
demonstrated during whole body exercise that leg blood flow and vascular conductance 
were lower in aged individuals compared to younger counterparts. Several potential 
problems with the experimental approach of using whole body exercise to determine 
whether local vascular factors limit skeletal muscle perfusion with aging is that the lower 
old age-associated exercise hyperemia could result from limited cardiac output (32, 56) 
or a smaller muscle mass (35) among elderly subjects.  To overcome these potential 
limitations, Lawrenson el al. (60) measured muscle blood flow and vascular resistance 
during small muscle mass knee extensor exercise which would not elicit maximal 
cardiac output and found that knee extensor blood flow was lower and vascular 
resistance higher across a range of work rates in aged men relative to young subjects. 
These findings indicate that local factors, such as decreased responsiveness to 
vasodilator stimuli and/or increased responsiveness to vasoconstrictor stimuli could 
underlie the old age-associated reduction in muscle blood flow during exercise (60). 
One of the potential local mechanisms that could mediate an impaired ability to 
increase skeletal muscle blood flow with aging is a diminished endothelium-dependent 
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vasodilator function. Furchgott and Zawadzki (34) firstly found the important role of the 
endothelium in the vasodilation of the vascular system caused by the endothelium-
dependent vasodilator ACh. They demonstrated the role of endothelial cells to release a 
factor that causes vasodilation in the vessel, termed endothelium-derived relaxing factor 
(EDRF), which modulates the vascular response (34). This factor has been identified as 
nitric oxide (NO) (81). NO synthesis is catalyzed by the constitutive enzyme, nitric 
oxide synthase (NOS), from the terminal guanidine of L-arginine, which is calcium 
(Ca++)/calmodulin-dependent (80). Since NO is rapidly diffusible, once it is synthesized, 
it can easily move into the smooth muscle cell through the cell membrane where it plays 
an important role in regulating the constriction of smooth muscle in the vascular system 
(33). 
Although the effect of aging on endothelium-dependent vasoreactivity varies 
with species and vascular beds (48, 112), aging-induced impairment of endothelial 
function in various vascular beds has been well documented (16, 21, 22, 30, 36, 46, 71, 
98, 118). Desouza et al. (22) reported that vascular responsiveness to the endothelium-
dependent vasodilator, ACh, is decreased, but vasodilatation to an endothelium-
independent vasodilator, nitroprusside, is unchanged in the forearm of aged humans. 
Woodman et al. (118) reported similar finding with isolated feed artery from the rat 
skeletal muscles. They found that endothelium-dependent dilation to ACh was lower in 
old soleus muscle feed arteries, whereas endothelium-independent dilation to sodium 
nitroprusside (SNP) was not different in skeletal muscle feed arteries from young and old 
rats. Moreover, our laboratory has shown similar results in the arterioles isolated from 
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skeletal muscle in aged rats. Specifically, it was reported that endothelium-dependent 
vasodilator responses to ACh are diminished with aging in first-order (1A) arterioles 
from the soleus muscle, a highly oxidative muscle, but not from the superficial portion of 
gastrocnemius muscle, a low-oxidative glycolytic muscle (71, 98). Furthermore, age-
related differences in ACh-induced vasodilatation of soleus muscle arterioles between 
young and old rats are abolished with NG-nitro-L-arginine methyl ester (L-NAME), a 
NOS antagonist (71, 98). These findings indicate that aging impairs endothelium-
dependent and NO-mediated vasodilatation in 1A soleus muscle arterioles.  
Long-term aerobic exercise training has been reported to ameliorate the age-
associated dysfunction of both central and peripheral cardiovascular function (78). For 
example, 16 weeks of endurance training results in a significant increase in leg blood 
flow and vasodilator capacity in both men and women (64). Also, cross-sectional studies 
report that physically active individuals and aged endurance athletes have greater 
endothelium-dependent vasodilation through the NOS mechanism (22, 106). Moreover, 
several animal studies have supported the finding that exercise training results in 
enhanced endothelium-dependent vasodilation in conduit arteries (19, 20) and skeletal 
muscle arterioles (71, 98). Spier et al. (98) reported that the exercise training-induced 
reversal of the age-related endothelial dysfunction in soleus muscle arterioles is 
mediated through the NO signaling pathway.  
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1.2 Aging, vasoconstrictor mechanisms of blood flow and exercise training 
In addition to impaired endothelium-dependent vasodilator function with aging, 
the age-associated reduction in skeletal muscle blood flow capacity could be due to an 
enhancement of resistance vessel vasoconstrictor responsiveness. Three major 
vasoconstrictor mechanisms have been described: noradrergic-, endothelin-1 (ET-1)- and 
Ang II- mediated mechanisms. Since these are potentially important factors that control 
muscle blood flow at rest and during exercise, understanding the mechanism of effects 
of aging and exercise training on these factors is important. 
Aging causes progressive increases in the sympathetic vasoconstrictor outflow to 
skeletal muscle in resting humans, and it is evidenced by elevations in muscle 
sympathetic nerve activity (MSNA) and basal norepinephrine (NE) spillover rates (97). 
However, age-associated responsiveness or sensitivity to α-adrenergic receptors is 
controversial. For example, no changes in age-associated responsiveness or sensitivity to 
α-adrenergic stimulation (26, 96), age-related attenuated vasoconstrictor responsiveness 
to sympathetic stimulation (14, 104), or elevated adrenergic sensitivity of the leg 
vasculature in older men (25, 54) have been reported. Although some studies have 
reported that leg blood flow is not changed with aging in isolated contracting muscles 
(51), in exercising rats (75), and in humans performing leg exercise (85), studies have 
supported an age-associated reduction in the ability to increase muscle blood flow during 
exercise as previously mentioned (50, 52, 60, 62, 86). Reductions in basal limb blood 
flow and vascular conductance with aging have been reported to be related to enhanced 
sympathetic α-adrenergic vasoconstriction (25). Koch et al. (54) reported greater 
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reduction in leg vascular conductance to sympathetic stimulation during exercise in older 
men whereas increase in sympathetic outflow to local cold stimulation during the cycle 
ergometer exercise was not different. Also, impaired functional sympatholysis in the 
forearm vascular beds during rhythmic handgrip exercise was found in older men 
indicating the impaired ability to blunt sympathetic α-adrenergic vasoconstriction with 
advancing age causing the reduction in blood flow to exercising muscle (24). 
Although the mechanisms through which aging and exercise training alter 
endothelium-dependent vasodilation have been previously investigated (21, 71, 98, 106), 
the effects of aging and exercise training on the modulation of vasoconstrictor responses 
in the peripheral resistance vasculature have not been clearly delineated. Alterations in 
resistance vessel sensitivity to vasoconstrictors may contribute to the age-related 
reduction in exercise tolerance and skeletal muscle blood flow capacity. The 
mechanisms through which aging and exercise training affect noradrenergic- and ET-1-
mediated vasoconstriction have been recently investigated in our laboratory (27, 28). 
Donato el al. (27) found that aging is associated with an augmented α-adrenergic 
vasoconstriction in soleus muscle arterioles and exercise training attenuated this 
augmentation in old rats.  The aging- and training-associated alterations in α-adrenergic 
vasoconstriction are mediated through an endothelium-dependent mechanism, since the 
aging and exercise training effects are abolished with the removal of the endothelium.  
Donato et al. (28) also reported that aging is associated with an enhancement of 
ET-1 sensitivity in 1A arterioles from the white portion of the gastrocnemius muscle, but 
not in 1A arterioles from the soleus muscle. This enhanced vasoconstrictor response to 
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ET-1 in gastrocnemius muscle arterioles from old rats is due to augmented 
vasoconstrictor response mediated through ETa receptors on the smooth muscle, but not 
through ETb receptors.  Thus, aging has been shown to enhance vasoconstrictor 
responses of skeletal muscle arterioles through α-adrenergic and ET receptors.  However, 
despite α-adrenergic and ET receptors both being present on vascular endothelial and 
smooth muscle cells, the aging and exercise training effects of α-receptor-mediated 
vasoconstriction occurred through the endothelial cells, whereas the aging effect 
mediated through the ETa-receptor occurred through the smooth muscle cells. No study 
has been reported that investigated the mechanisms for the effects of aging and training 
on Ang II-induced vasoconstriction, which is one of the possible vasoconstriction 
mechanisms in the skeletal muscle arterioles. 
1.3 Ang II 
Ang II is the main biologically active peptide of the renin-angiotensin system 
(RAS), which plays a major physiological role in regulation of the cardiovascular system. 
Disorders of the RAS are associated with the pathophysiology of renal diseases, 
hypertension, and chronic heart failure (61).  Ang II is generated by the angiotensin-
converting enzyme (ACE), which is an ectoenzyme that catalyzes the extracellular 
conversion of Ang I to Ang II. Also, another enzyme, renin, is involved in regulation of 
the Ang II synthesis in the RAS. Renin is released from the juxtaglomerular cells of the 
kidney into the circulation where it converts angiotensinogen to Ang I.  Ang II also plays 
an important physiological role in the regulation of blood pressure, plasma volume, and 
sympathetic nervous activity (7); it is in this capacity that Ang II, as a potent 
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vasoconstrictor, can serve to regulate blood flow through alteration in vascular tone and 
conductance, and ultimately serve to regulate mean arterial blood pressure (102, 105).  
The vascular effects of Ang II are mediated through direct action of Ang II on 
Ang II receptors. Final cardiovascular responses to Ang II are determined by the result 
of combined action of Ang II receptors. Two major subtypes of Ang II receptors have 
been mainly defined on the basis of their different pharmacological and biochemical 
properties: Ang II type 1 receptor (AT1R) and Ang II type 2 receptor (AT2R) (53, 69, 74).  
The locations of AT1R and AT2R vary depending on species of animal and tissue 
type. AT1R are located in the cardiovascular, renal, endocrine, and nervous systems in 
humans (3). In the vasculature, AT1R are primarily concentrated on smooth muscle cells 
with relatively low levels in the adventitia (2, 121) and endothelial cells (88). In contrast 
to AT1R, AT2R are highly present in fetal tissues, and its expression is rapidly decreased 
after birth, but, in adults, AT2R expression is detectable in various tissues including the 
vasculature (1). AT2R are expressed both in endothelial and smooth muscle cells in rat 
mesenteric arteries and skeletal muscle arterioles (65, 77).  
AT1Rs are involved in most of the well-known physiological effects of Ang II, 
and this subtype is the major effector mechanism of Ang II-mediated vascular functions 
(92). Activation of AT1R results in stimulation of vasoconstriction, vascular cell 
hypertrophy and hyperplasia, and sodium retention (7). Also, physiological effects of 
this receptor have also been reported to include stimulation of reactive oxygen species 
(ROS) (89) and induction of inflammatory (72), thrombotic (113), and fibrotic (107) 
processes. In terms of vasoconstriction, binding of Ang II to AT1R stimulates G protein-
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coupled activation of phospholipase C (PLC) and results in phosphatidylinositol (PIP3) 
hydrolysis and formation of inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 
activates the movement of Ca2+ from sarcoplasmic reticulum (SR), and DAG leads 
protein kinase C (PKC) to activate the sodium/hydrogen (Na+/H+) exchanger (110). 
Consequently, it results in increased intracellular free Ca2+ concentration and actin-
myosin interaction in vascular smooth muscle cells and, subsequently, vascular smooth 
muscle contraction. Thus the overall signaling pathway through AT1R binding results in 
vasoconstriction in the vasculature (110).  
AT2R has a less well-defined role in the cardiovascular system, but there is 
growing evidence that the AT2R plays an important role in cardiovascular physiology. 
Overall, AT2R appears to counter-regulate the excitatory effect of AT1R, including 
vasodilation, antigrowth, antihypertrophic effects, and depressor regulation of blood 
pressure (11, 47, 66).  There are evidences showing AT2R has a significant role to 
control vascular tone by mediating vasodilation and counterbalancing the AT1R-
mediated vasoconstriction of Ang II. AT2R stimulates endothelium-dependent 
vasodilation by release of NO (11, 61), which counteracts with the direct smooth muscle 
contraction that is mainly mediated by the AT1R. Moreover, Ichiki et al. (49) found that 
AT2R knock-out mice have higher blood pressure compared to the wild-type control 
mice, and Munzenmaier et al. (73) reported that pharmacological blockade of AT2R 
augments the pressor effect of Ang II in the rat. AT2R–mediated signaling works through 
a G protein coupling mechanism to mediate cardiovascular actions (47). Binding to 
AT2R stimulates several cascades, including activation of protein phosphatases and 
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protein dephosphorylation, stimulation of phospholipase A (PLA2) and release of 
arachidonic acid (AA), sphingolipid-derived ceramide, and increase in cyclic guanosine 
3',5'-monophosphate (cGMP) level through a NO mechanism, which cause the 
vasodilation (47).  
It has been well-documented that activation of AT1R mediates vasoconstriction 
of conduit coronary arteries (103), but several studies relating to pharmacological 
properties suggest that AT2R may mediate vasodilation of large conduit vessels (95, 117) 
and the coronary microcirculation (119) through the endothelium. In addition, studies 
have reported that, in endothelial cells, AT1R plays a role of vasodilation through an 
eNOS mechanism (8), whereas activation of AT2R on the smooth muscle cells exert a 
functional vasodilation via neuronal NOS (nNOS) and a soluble guanylate cyclase (sGC) 
pathway (15). Since Ang II exerts direct effects on both endothelial and smooth muscle 
cells in the vasculature, Ang II-induced vasoconstriction is determined by the net 
interactions between smooth muscle and endothelial cells. In order to explain the 
mechanisms of Ang II-induced vasoconstriction to control blood flow, Ang II-induced 
vasodilation through the endothelium is also critical (40), although the majority of 
studies in the literature have focused on the Ang II-induced vasoconstriction role 
through smooth muscle. Moreover, Gruetter et al. (38) reported that Ang II-induced 
vasoconstriction is attenuated by the release of a substance from the endothelium and 
enhanced by removal of endothelium. Specifically, Ang II activates NO production by 
vascular endothelial cells through AT1R activation (10) and/or through AT2R activation 
(93, 116). Therefore, identifying the interaction between the smooth muscle and 
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endothelial cell response is important for understanding the mechanism(s) of effects of 
aging and exercise training on Ang II-induced vasoconstriction in resistance arterioles. 
Ang II has been shown to play a role in the vasomotor activity in various 
microvascular beds (44), but few studies investigating the direct effects of Ang II on the 
microcirculation have been performed. The degree of Ang II-induced vasoconstriction 
gradually diminishes with increasing Ang II concentration above a certain point of 
concentration.  Zhang et al. (119) recently reported that the more potent vasoconstriction 
occurs at a lower concentration of Ang II (1nmol/L), where there is less vasoconstriction 
at higher concentrations (10nmol/L) in coronary arterioles. This is consistent with the 
findings in the perfused heart showing that the magnitude of coronary vasodilation is 
increased with increasing Ang II concentrations (83). This lower constrictor response at 
higher concentrations of Ang II may depend on the interaction of the smooth muscle cell 
and endothelial cell response to Ang II.  
1.4 Aging, exercise, and Ang II 
Limited information is available regarding changes in Ang II vasoreactivity with 
aging in the microcirculation. Although aging is associated with lower plasma renin 
activity in normal individuals (115), evidence suggests no aging effect on plasma Ang II 
concentration (29). Moreover, few studies have investigated possible changes of Ang II 
receptor density with aging, and what has been reported provides no clear pattern. 
Daubert et al. (13) reported that the density of Ang II receptor binding sites is lower in 
old mouse brains, whereas Heymes et al. (45) found that mRNA levels of both AT1R and 
AT2R subtypes are markedly up-regulated in the myocardium of aged rats. More 
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significantly, the effect of aging on Ang II-induced vasoconstriction in skeletal muscle 
arterioles has not been shown, although understanding the effect of aging on Ang II-
induced vasoconstriction in skeletal muscle arterioles may be potentially important since 
Ang II-induced vasoconstriction may be one of the important contributing factors to the 
age-associated reduction in blood flow to skeletal muscles during exercise. 
During dynamic exercise, the plasma Ang II levels are increased in an intensity-
dependent manner (101, 108), and as a result, Ang II may be more involved in 
determining the blood flow response during exercise. Ang II is a potent vasoconstrictor 
in the cardiovascular system during exercise (102, 105) in that it increases the pressor 
response and may be involved in redirecting blood flow from the splanchnic and renal 
regions toward active muscles (102). However, no study has been reported regarding the 
effect of long-term exercise training on Ang II-induced changes in blood flow and 
vascular conductance. Moreover, the effect of exercise training on Ang II-induced 
vasoconstriction in the skeletal muscle resistance vessels also has not been investigated. 
Overall, the role of Ang II has been investigated in the control of blood flow and 
vascular conductance during acute exercise. However, studies on the effect of aging and 
endurance exercise training on Ang II-mediated vascular responses are lacking. 
1.5 Purpose and hypotheses 
The central hypothesis for this study is that aging diminishes vascular 
conductance due to a shift of interaction between vascular smooth muscle cells and 
endothelial cells, and that exercise training serves to attenuate this effect.  One possible 
mechanism for old age-related reductions in vascular conductance is an enhanced 
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vasoconstrictor responsiveness to Ang II, and that exercise training may serve to 
diminish Ang II-mediated vasoconstriction. 
 The overall purpose of this dissertation research is to determine whether aging 
alters Ang II vasoreactivity in skeletal muscle resistance arterioles and whether exercise 
training can ameliorate the putative old age-associated alteration in Ang II-induced 
vasoconstriction. A secondary purpose is to elucidate the mechanism(s) of the aging and 
exercise training effects on Ang II-induced vasoconstrictor response of skeletal muscle 
resistance arterioles from old rats. Therefore, six hypotheses were tested: 
1) There will be higher Ang II-induced vasoconstriction of arterioles from soleus 
and gastrocnemius muscles in old rats compared to that in young animals. 
2) Removal of the endothelium will abolish the age-associated difference of Ang 
II-mediated vasoconstriction in arterioles from soleus and gastrocnemius 
muscles. 
3) Inhibition of NOS activity with L-NAME will abolish the age-associated 
difference in Ang II-mediated vasoconstriction in soleus and gastrocnemius 
muscle arterioles. 
4) Exercise training will decrease Ang II-mediated vasoconstriction in aged 
arterioles from soleus and gastrocnemius muscles to levels at or near that in 
young sedentary animals. 
5) Removal of endothelium will abolish the exercise training-associated reduction 
in Ang II-mediated vasoconstriction in aged arterioles from soleus and 
gastrocnemius muscles. 
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6) Inhibition of NOS activity with L-NAME will abolish the exercise training-
associated reduction of Ang II-mediated vasoconstriction in aged arterioles 
from both soleus and gastrocnemius muscles. 
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CHAPTER II 
 
EFFECTS OF AGING AND EXERCISE TRAINING ON THE MECHANISMS 
OF ANGIOTENSIN II-INDUCED VASOCONSTRICTION IN RAT SKELETAL 
MUSCLE ARTERIOLES 
 
2.1 Introduction 
It is well documented that aging has a detrimental effect on the cardiovascular 
system and that aging is an independent risk factor for cardiovascular diseases, such as 
atherosclerosis, hypertension, and coronary artery disease (31). In addition to increased 
risk of cardiovascular disease with aging, aerobic exercise capacity declines with 
advancing age. This decline in exercise capacity is partly due to an attenuated ability to 
increase blood flow to working muscle during exercise, through both declines in 
maximal cardiac output (63) and skeletal muscle blood flow during exercise (60).  
One of the potential local mechanisms that could mediate an impaired ability to 
increase skeletal muscle blood flow with aging is an impaired endothelium-dependent 
and nitric oxide (NO)-mediated vasodilator function (16, 21, 22, 30, 36, 46, 71, 98, 118). 
Long-term aerobic exercise training has been also reported to ameliorate the age-
associated dysfunction through the endothelium-dependent vasodilation and the NOS 
signaling pathway mechanism in humans and animals (22, 98, 106). 
Although the mechanisms through which aging and exercise training alter 
endothelium-dependent vasodilation have been previously investigated, the effects of 
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aging and exercise training on the modulation of vasoconstrictor responses in the 
peripheral resistance vasculature have not been clearly delineated. Recently, however, 
Donato el al. (27) reported that aging is associated with an augmented α-adrenergic 
vasoconstriction in soleus muscle arterioles and exercise training attenuates this 
augmentation in old rats through an endothelium-dependent mechanism. Donato et al. 
(28) also found that aging is associated with an enhancement of ET-1 sensitivity in 1A 
arterioles from the white portion of the gastrocnemius muscle through augmented 
vasoconstrictor response mediated through ETa receptors on the smooth muscle and not 
through the endothelium.   
Ang II is the main biologically active peptide of the renin-angiotensin system 
(RAS), which exerts both hemodynamic and renal effects.  Ang II also plays an 
important physiological role in the regulation of blood pressure, plasma volume, and 
sympathetic nervous activity in the cardiovascular system (7).  In regard to the 
regulation of blood pressure, Ang II is a potent substance capable of constricting 
arterioles. Two subtypes of Ang II receptors have been mainly defined on the basis of 
their different pharmacological and biochemical properties.  Ang II type 1 receptor 
(AT1R), which is involved in most of the well-known physiological effects of Ang II and 
exerts potent vasoconstriction in the blood vessels, and Ang II type 2 receptor (AT2R), 
which has a less well-defined role but appears capable of counterbalancing some of the 
effects of AT1R stimulation (53, 69, 74). However, studies have reported that, in 
endothelial cells, AT1R also plays a role of vasodilation through an eNOS mechanism (8, 
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87), whereas activation of AT2R in the smooth muscle cell still exert a functional 
vasodilation via nNOS and sGC pathway (15). 
Since Ang II exerts direct effects on both endothelial and smooth muscle cells in 
the vasculature, Ang II-induced vasoconstriction is determined by the interaction of 
vasoconstrictor and vasodilator influences mediated by smooth muscle and endothelial 
cells. Therefore, understanding the role of the smooth muscle and endothelial cells is 
important to elucidate the mechanism(s) of the effect of aging and exercise training on 
Ang II-induced vasoconstriction in the resistance arteriole.  
Limited information is available regarding changes in Ang II vasoreactivity with 
aging in the microcirculation. Moreover, no direct studies have been conducted 
regarding the effects of aging or exercise training on Ang II-induced vasoconstriction in 
skeletal muscle arterioles. Therefore, the purpose of this study is to determine whether 
and through what mechanism(s) aging and exercise training affect Ang II-mediated 
vasoconstriction in rat skeletal muscle resistance arterioles. Based on results showing 
age enhances α-adrenoceptor-mediated vasoconstriction via diminished endothelium 
dependent NOS mechanism (27), we hypothesized that aging would enhance Ang II-
induced vasoconstriction through an impaired endothelium-dependent NOS signaling 
pathway, and that exercise training would attenuate the increased Ang II-mediated 
vasoconstriction through the endothelium NOS mechanism. 
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2.2 Methods 
2.2.1 Animals 
Male Fischer 344 young (3-6 months) and old (22-24 months) rats were obtained 
from the National Institutes for Aging (NIA/Harlan) and housed in a temperature-
controlled (23±2°C) room with a 12:12 light-dark cycle. Water and rat chow were 
provided ad libitum. All animal procedures were approved by the Texas A&M 
University Laboratory Animal Care Committee and complied with the guidelines of the 
National Research Council Guide for the Care and Use of Laboratory Animals. 
2.2.2 Exercise Training 
Training consisted of the following 10-12 weeks running program, executed on a 
motor-driven treadmill. During habituation, the rats walked on the treadmill at 10 m/min 
(0° incline) and then speed was increased to 15 m/min, 5 min/day for 3 days.  After 
habituation on the treadmill, young and old rats were assigned to one of four groups, 
young sedentary (YS), young exercise-trained (YT), old sedentary (OS), and old 
exercise-trained (OT). Exercise-trained rats performed treadmill running at 15 m/min on 
a 15° incline, 60 min/day, 5 days a week for 10 to12 weeks as previously described (20, 
98). A minimum of 48 hours was allowed between the execution of experiments and the 
final bout of exercise. 
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2.2.3 Microvessel Preparation 
The rats were anesthetized with pentobarbital sodium (60 mg/kg ip) and the 
gastrocnemius-plantaris-soleus muscle group from the hindlimb was carefully dissected 
free and placed in cold (4°C) physiological saline solution (PSS) that contained 
145.0 mM NaCl, 4.7 mM KCl, 2.0 mM CaCl2, 1.17 mM MgSO4, 1.2 mM NaH2PO4, 
5.0 mM glucose, 2.0 mM pyruvate, 0.02 mM EDTA, 3.0 mM MOPS buffer, and 1 g/100 
ml BSA at pH 7.4. With a dissecting microscope (Olympus SVH10), 1A arterioles from 
the soleus muscle and the white portion of the gastrocnemius muscle were isolated and 
removed from the surrounding muscle tissue as previously described (67, 70). The 
arterioles were transferred to a Lucite chamber that contained PSS equilibrated with 
room temperature. Each end of the arteriole was cannulated with a micropipette and 
secured with nylon suture. After cannulation of the arterioles, the microvessel chamber 
was transferred to the stage of an inverted microscope (Olympus IX70) equipped with a 
video camera (Panasonic BP310), video caliper (Microcirculation Research Institute), 
and data acquisition system (MacLab/Macintosh) for on-line recording of intraluminal 
diameter. The arterioles were initially pressurized to 70 cmH2O with two independent 
hydrostatic pressure reservoirs. Leaks were detected by pressurizing the vessel and then 
closing the valves to the reservoirs and verifying that intraluminal pressure remained 
constant. The arterioles that did not hold pressure were discarded. The arterioles that 
were free from leaks were warmed to 37°C and allowed to develop initial spontaneous 
tone during a 30- to 60-min equilibration period.  
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2.3.4 Experimental Design 
Protocol I. Concentration-response relations to the cumulative addition of Ang II 
[3×10-11 to 3×10-5 M] were determined in arterioles from the soleus and gastrocnemius 
muscles from YS, OS, YT, and OT groups. Diameter was recorded for 3 minutes 
following each addition of Ang II. The arterioles were allowed to develop at least 15% 
spontaneous tone prior to addition of Ang II. 
Protocol II. To determine whether alterations induced by aging and exercise 
training from protocol I were mediated through the vascular endothelium, the 
endothelium was denuded from the gastrocnemius and soleus muscle arterioles from the 
YS, YT, OS, and OT by passing 5 ml of air through the lumen of the vessel. In order to 
insure full removal of the endothelium, the arterioles were exposed to ACh [3×10-5 M]. 
Vessels that exhibited vasodilation of more than 5% were excluded from further study. 
Following the ACh test, the vessels were washed several times with PSS and allowed to 
develop spontaneous tone prior to the Ang II dose response. The diameters of denuded 
1A arterioles from gastrocnemius and soleus muscles were measured in response to 
increasing concentrations of Ang II [3×10-11 to 3×10-5 M]. 
Protocol III. Since results from protocol II indicated that the effects of aging and 
exercise training were endothelium-dependent, another series of studies was performed 
to determine whether the alteration of the endothelium by aging and exercise training 
was mediated through the NOS signaling pathway. After the arterioles were allowed to 
develop spontaneous tone, they were incubated for 20 minutes with L-NAME [10-5 M] 
and the Ang II dose response [3×10-11 to 3×10-5 M] was performed. 
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2.2.5 Muscle Citrate Synthase Activity 
Sections of the soleus and white gastrocnemius muscles from each animal were 
stored at -80°C for determination of citrate synthase activity (100), a measures of muscle 
oxidative capacity, to determine the efficacy of the training regimen. Likewise, the heart 
was removed to determine whether exercise training elevated heart-to body mass ration, 
an indicator of an exercise trained state. 
2.2.6 Data Analysis 
Actual diameter was measure in response to Ang II and was expressed as a 
percentage of constrictor response according to the following formula:   
Vasoconstriction (% Maximal Response) = [(Db – Ds)/(Db) ×100]  
where Db is the initial baseline diameter recorded immediately before the addition of the 
Ang II and Ds is the steady-state diameter measured after each dose of Ang II. Dose 
response curves were analyzed by two-way ANOVA with repeated measure on one 
factor (Ang II dose). Pairwise comparisons between specific levels were made through 
post-analysis (LSD). A one-way ANOVA was performed to determine significance of 
differences among groups in citrate synthase activity, body weight, and muscle weight. 
All values were presented as mean ± SEM. Significant differences were indicated by P ≤ 
0.05. 
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2.3 Results 
2.3.1 Animal Characteristics 
The animals’ age at the time of study was approximately 6 months (range, 4-7 
month) for the young rats and 25 months (range, 24-25 month). Body mass was greater 
in old sedentary than in young sedentary rats (YS: 342 ± 6 g; OS: 431 ± 4 g), and 
exercise training reduced body mass in old rats (OS: 431 ± 4 g; OT: 396 ± 6 g), but not 
in young rats (YS: 342 ± 6 g; YT: 331 ± 7 g) (Table 2.1).  Although only soleus muscle 
mass was increased with age, both soleus and gastrocnemius muscle mass-to-body mass 
ratio were decreased with aging and exercise training in young and old rats. Also, only 
soleus muscle mass-to-body mass ratios was increased with exercise training in young 
and old rats (Table 2.1). 
Heart mass and left ventricle mass-to-body mass ratio were higher in the exercise 
trained groups and citrate synthase activity was higher in soleus muscle from both young 
and old trained rats (Soleus; YS 20.0 ± 0.6, OS: 17.5 ± 0.9, YT: 25.9 ± 0.9, OT: 23.4 ± 
1.3) indicating the efficacy of the exercise training regimen (P<0.05). However, citrate 
synthase activity in the white portion of gastrocnemius was not altered by exercise 
training in either young or old rats (Table 2.1). 
2.3.2 Isolated Vessel Characteristics 
Maximal intraluminal diameters of soleus muscle arterioles were not different 
among groups, but maximal intraluminal diameters of gastrocnemius muscle arterioles 
were increased with age. Exercise training tended to increase maximal diameter of 
gastrocnemius muscle arterioles in old rats (P=0.057) (YS: 151 ± 4, OS: 172 ± 5, YT: 
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156 ± 7, OT: 188 ± 7) (Table 2.2). Initial spontaneous tone developed was not different 
among groups in arterioles from soleus and gastrocnemius muscles. 
2.3.3 Ang II Vasoconstrictor Studies 
Vascular sensitivity (EC50). There were no aging and exercise training effect on 
vascular sensitivity (EC50) in the rat skeletal muscle arterioles (Table 2.3). 
Effect of aging. Aging enhanced Ang II-mediated vasoconstrictor response in the 
1A arterioles from both soleus (Figure 2.1 A) and gastrocnemius (Figure 2.1 B) muscles.  
Vasoconstrictor response to single dose of Ang II. Ang II-induced 
vasoconstriction with a single dose of Ang II at the concentration of 1×10-8 M also 
resulted in a higher vasoconstrictor response in aged arterioles from soleus (A) and 
gastrocnemius (B) muscles (Figure 2.2). This difference was similar to the concentration 
with the cumulative addition of Ang II (Figure 2.1). These results indicate that the 
difference in Ang II-induced vasoconstriction between young and old skeletal muscle 
arterioles is concentration-dependent, not time-dependent. 
Effect of removal of endothelium. The biphasic responses of Ang II-mediated 
vasoconstriction, which is a lower vasoconstrictor response at higher concentration of 
Ang II (higher than 3×10-7 M), were abolished with the removal of the endothelium in 
both young and old rats (Figure 2.3). More importantly, the removal of the endothelium 
resulted in an elimination of the age-associated difference in Ang II-mediated 
vasoconstriction of soleus (Figure 2.3 A) and gastrocnemius (Figure 2.3 B) muscle 
arterioles from young and old rats.
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Table 2.1     Animal characteristics of YS, OS, YT, and OT groups. 
 Sedentary Exercise-Trained 
 Young (YS) Old (OS) Young (YT) Old (OT) 
N 29 29 23 20 
Body Mass (g) 342 ± 6 431 ± 4* 331 ± 7 396 ± 6‡
Soleus Muscle Mass 
(mg) 150 ± 4 170 ± 4
* 158 ± 5 174 ± 6 
Gastrocnemius Muscle 
Mass (mg) 1,756 ± 33 1,804 ± 37 1,713 ± 30 1,702 ± 47 
Soleus Muscle 
Mass/Body Mass  
Ratio (mg/kg) 
441 ± 10 395 ± 10* 480 ± 13† 438  ± 12‡
Gastrocnemius Muscle 
Mass/Body Mass  
Ratio (mg/kg) 
5,160 ± 98 4,182 ± 85* 5,208 ± 119 4,295 ± 94 
Heart Mass (mg) 909 ± 33 1,168 ± 37* 949 ± 36 1,176 ± 37 
Heart Mass/Body Mass 
Ratio (mg/kg) 2,657 ± 124 2,709 ± 94 2,867 ± 90
† 2,969 ± 117‡
LV Mass/Body Mass 
Ratio (mg/kg) 1,822 ± 71 1,887 ± 35 2,252 ± 59
† 2,215 ± 66‡
Soleus muscle citrate 
synthase activity 
(µmol/min/g wet Wt) 
20.0 ± 0.6 17.5 ± 0.9* 25.9  ± 0.9† 23.4  ± 1.3‡
White portion of 
gastrocnemius  muscle 
citrate synthase activity 
(µmol/min/g wet Wt) 
12.0 ± 0.3 12.1 ± 0.6 12.1 ± 0.6 13.0 ± 1.0 
Wt is weight; LV is left ventricle. * indicates significant difference between young sedentary and 
old sedentary, † indicates significant difference between young sedentary and young trained, ‡ 
indicates difference between old sedentary and old trained, P<0.05. Values are means ± SEM 
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Table 2.2    Characteristics of 1A arterioles from soleus and the superficial portion of 
gastrocnemius muscles from YS, OS, YT, and OT groups. 
 
 Sedentary Exercise-Trained 
 Young (YS) Old (OS) Young (YT) Old (OT) 
N 36 32 21 15 
Soleus Muscle 
Arteriole Lumen 
Diameter (µm) 
120 ± 3 125 ± 4 112 ± 4 118 ± 4 
Gastrocnemius Muscle 
Arteriole Lumen 
Diameter (µm) 
151 ± 4 172 ± 5* 156 ± 7 188 ± 7 
Soleus Muscle 
Arteriole Spontaneous 
Tone (%) 
51 ± 3 45 ± 3 50 ± 4 40 ± 4 
Gastrocnemius Muscle 
Arteriole Spontaneous 
Tone (%) 
45 ± 3 40 ± 3 50. ± 4 47 ± 4 
* indicates significant difference between young sedentary and old sedentary, † indicates 
significant difference between young sedentary and young trained, ‡ indicates difference 
between old sedentary and old trained, P<0.05. Values are means ± SEM  
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Table 2.3 Vascular sensitivity (EC50) to Ang II in arterioles from soleus and the 
superficial portion of gastrocnemius muscles. 
 
 Soleus Muscle 
Arterioles EC50 
(M) 
Gastrocnemius Muscle 
Arterioles EC50 
(M) 
YS 2.3 E−10 ± 0.6 E−10 1.5 E−10 ± 0.3 E−10
YS-E 2.4 E−9 ± 1.0 E−9 1.7 E−8 ± 0.3 E−8 
#Young 
(YS) 
YS+L-NAME 4.0 E−9 ± 2.2 E−9 1.9 E−8 ± 0.9 E−8
OS 3.0 E−10 ± 1.5 E−10 1.6 E−10 ± 0.5 E−10
OS-E 8.6 E−9 ± 6.6 E−9
 #
7.4 E−8 ± 3.4 E−8
 #
Sedentary 
Old 
(OS) 
OS+L-NAME 4.0 E−9 ± 2.2 E−9 2.6 E−8 ± 1.1 E−8 Ψ
YT 1.2 E−10 ± 0.4 E−10 1.3 E−10 ± 0.6 E−10
YT-E 1.0 E−8 ± 0.4 E−8 1.3 E−8 ± 0.7 E−8Young (YT) 
YT+L-NAME 1.6 E−8 ± 0.6 E−8
 § 7.0 E−9 ± 3.2 E−9
OT 1.7 E−10 ± 0.6 E−10 1.5 E−10 ± 0.5 E−10
OT-E 1.8 E−8 ± 1.0 E−8
 #
6.4 E−8 ± 1.4 E−8 
#
Exercise-
Trained 
Old 
(OT) 
OT+L-NAME 6.7 E−9 ± 3.4 E−9 1.4 E−9 ± 0.5 E−9 Ψ
-E is endothelium removed. # indicates significant effect of removal of endothelium, § 
indicates significant effect of treatment of L-NAME, Ψ indicates significant different between 
endothelium removed and L-NAME, P<0.05. Values are means ± SEM 
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Figure 2.1 Comparison of vasoconstrictor response to the cumulative addition of Angiotensin 
II between young sedentary (YS) and old sedentary (OS) in soleus (A) and 
gastrocnemius (B) muscle arterioles. Values are means ± SEM. 
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Figure 2.2 Comparison of vasoconstrictor response to the single dose of Angiotensin II 
[10-8 M] between young sedentary (YS) and old sedentary (OS) in soleus (A) and 
gastrocnemius (B) muscle arterioles. Values are means ± SEM. * indicates 
significantly different between YS and OS. (P<0.05) 
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Figure 2.3  Effect of removal of endothelium on vasoconstrictor response to the cumulative 
addition of Angiotensin II among young sedentary (YS), endothelium removed 
young sedentary (YS-E), old sedentary (YS) and endothelium removed old 
sedentary (OS-E) in soleus (A) and gastrocnemius (B) muscle arterioles. Values are 
means ± SEM. 
 
 31
Effect of NOS inhibition. Treatment with L-NAME resulted in a linear increase 
in the vasoconstrictor response to Ang II rather than the biphasic response occurring at 
the higher concentrations of Ang II in soleus and gastrocnemius muscle arterioles. 
(Figure 2.4). More importantly, age-related difference in Ang II-mediated 
vasoconstriction of soleus (Figure 2.4 A) and gastrocnemius (Figure 2.4 B) muscle 
arterioles were abolished by the removal of the endothelium. 
Effect of exercise training. Exercise training decreased Ang II-mediated 
vasoconstrictor responses in arterioles from both soleus (P<0.05) (Figure 2.5 A) and 
gastrocnemius (P<0.05) (Figure 2.5 B) muscles of old rats, but training had no effect on 
arterioles from young rats from the soleus (P=0.607) and gastrocnemius (P=0.965) 
muscles.  
Effect of removal of endothelium in old exercise trained arterioles. Following 
removal of vascular endothelium, the above-mentioned exercise training-mediated 
alterations in Ang II-induced vasoconstriction of soleus (Figure 2.6 A) and 
gastrocnemius (Figure 2.6 B) muscle arterioles from old rats were abolished. 
Effect of NOS inhibition in old exercise trained arterioles. In the presence of L-
NAME, the training-related decrease in Ang II-mediated vasoconstriction of old rat 
soleus (Figure 2.7 A) and gastrocnemius (Figure 2.7 B) muscle arterioles were likewise 
abolished.
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Figure 2.4 Effect of L-NAME on vasoconstrictor response to the cumulative addition of 
Angiotensin II among young sedentary (YS) young sedentary with L-NAME 
(YS+L-NAME), old sedentary (OS) and old sedentary with L-NAME (OS+L-
NAME) in soleus (A) and gastrocnemius (B) muscle arterioles. Values are means ± 
SEM. 
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Figure 2.5 Effect of exercise training on vasoconstrictor response to the cumulative addition of 
Angiotensin II among young sedentary (YS), young exercise trained (YT), old 
sedentary (OS) and old exercise trained (OT) in soleus (A) and gastrocnemius (B) 
muscle arterioles. Values are means ± SEM. 
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Figure 2.6 Effect of removal of endothelium on vasoconstrictor response to the cumulative 
addition of Angiotensin II among old sedentary (OS), old exercise trained (OT), 
endothelium removed old sedentary (OS-E), and endothelium removed old exercise 
trained (OT-E) in old soleus (A) and gastrocnemius (B) muscle arterioles. Values 
are means ± SEM. 
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Figure 2.7 Effect of L-NAME on vasoconstrictor response to the cumulative addition of 
Angiotensin II among old sedentary (OS), old exercise trained (OT), old sedentary 
with L-NAME (OS+L-NAME), and old exercise trained with L-NAME (OT+L-
NAME) in old soleus (A) and gastrocnemius (B) muscle arterioles. Values are 
means ± SEM. 
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Figure 2.8 Comparison of effect of removal of endothelium and L-NAME on vasoconstrictor 
response to the cumulative addition of Angiotensin II in young and old sedentary 
soleus (A) and gastrocnemius (B) muscle arterioles. Values are means ± SEM. 
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Figure 2.9 Comparison of effect of removal of endothelium and L-NAME on vasoconstrictor 
response to the cumulative addition of Angiotensin II in young and old exercise 
trained soleus (A) and gastrocnemius (B) muscle arterioles. Values are means ± 
SEM. 
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Comparison between removal of endothelium and L-NAME. Ang II-mediated 
vasoconstriction appeared to be identical between arterioles with the endothelium 
removed and those treated with L-NAME from young and old soleus muscle (Figure 
2.8). In both young and old exercise trained arterioles from soleus muscle, the effects of 
removal of the endothelium on Ang II-mediated vasoconstriction were also not different 
from treatment with of L-NAME (Figure 2.9 A). However, in arterioles from exercise 
trained gastrocnemius muscle, Ang II-mediated vasoconstriction in L-NAME treated 
arterioles was higher compared to endothelium removed arterioles in old trained rats; 
responses in young trained rat gastrocnemius muscle arterioles were not different (Figure 
2.8 B). 
 
2.4 Discussion 
The purpose of this study was to determine 1) whether aging alters Ang II-
induced vasoconstriction of skeletal muscle arterioles, 2) whether exercise training 
modulates Ang II-induced vasoconstriction in young and old animals, and 3) 
mechanisms of putative aging- and exercise training-induced differences in Ang II-
induced vasoconstriction in skeletal muscle arterioles. The present study provides 
several unique findings. First, aging enhances Ang II-induced vasoconstrictor responses 
in arterioles from both the highly oxidative soleus muscle and low-oxidative superficial 
portion of gastrocnemius muscle. Second, the age-associated enhancement of Ang II-
induced vasoconstriction occurs through an endothelium-dependent NOS signaling 
mechanism. And third, exercise training ameliorates the age-associated increase in Ang 
 39
II-mediated vasoconstriction in both soleus and gastrocnemius muscles, and this too 
occurs through an endothelium-dependent NOS signaling pathway. 
2.4.1 Determination of Ang II-induced vasoconstriction 
Unlike  other vasoconstrictor responses in the vasculature, Ang II-induced 
vasoconstriction is a biphasic response, where the most potent vasoconstriction occurs at 
the lower concentrations of Ang II (119). Our results (Figure 2.1) are consistent with 
those findings showing lower vasoconstrictor responsiveness with the highest 
concentrations of Ang II. Many studies have reported that activation of AT1R results in 
vasoconstriction through increased Ca++ availability in the smooth muscle cell and 
binding to AT2R causes vasodilation through increased NO synthesis (7, 11, 42, 65, 110). 
Thus, it appears that the net Ang II-induced vasoconstriction is the result of an 
interaction between vasoconstrictor influence via AT1R and vasodilator influence 
through AT2R. However, this view may be somewhat misleading for gaining 
understanding of the mechanisms of Ang II-induced vasoconstriction because several 
studies have reported the presence of vascular endothelial cell AT1R which ,when 
stimulated, result in vasodilation (8, 87). What is clear is that the endothelium plays a 
very important role in modulating Ang II-induced contraction of blood vessels through 
an endothelium dependent vasodilator mechanism (8, 38, 40, 109, 120). Therefore, Ang 
II-induced vasoconstriction may be determined by the interaction of vasoconstrictor 
signals mediated through AT1R and the vasodilator influence mediated through 
endothelial cells AT1R and AT2R. Although AT2R are also located on smooth muscle 
cells in various vascular beds which mediate vasodilation (15), vasoconstriction 
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mediated through AT1R is the predominant smooth muscle cell response. Our findings in 
skeletal muscle arterioles support the idea that the endothelium plays an important role 
in determining the biphasic Ang II-induced vasoconstrictor response (Figure 2.3). 
2.4.2 Age-associated enhancement in Ang II-induced vasoconstriction 
In humans, it has been shown that aging results in lower leg blood flow at rest 
and during exercise (5, 23, 60, 82, 84, 86). Although an impairment of endothelium-
dependent vasodilator function has been reported as a mechanism for this age-associated 
decrease in muscle blood flow in human (21, 71, 98, 118) and rats (21, 71, 98, 118), the 
role of vasoconstrictor mechanisms to explain the reduced blood flow capacity to the 
skeletal muscle with advancing aging has not been as thoroughly explored. Recently, our 
laboratory found that old age-related reductions in the ability to increase muscle blood 
flow during exercise may be due to alterations in vasoconstrictor responsiveness. Donato 
et al. (27, 28) found that an augmented α-adrenergic vasoconstriction and ET 1-mediated 
vasoconstriction may play an important role in determining age-associated reduction in 
skeletal muscle blood flow. One other possible vasoconstrictor mechanism may be an 
enhanced Ang II-mediated vasoconstriction, since it is well established that Ang II acts 
as a potent vasoconstrictor (102). Studies concerning the effect of aging on Ang II-
induced vasoconstriction are limited and equivocal. Mixed findings have been reported 
regarding the effect of aging on Ang II-related vascular responses; decreased vascular 
responsiveness to Ang II in aorta in rats with advancing age (9) and no effect of aging on 
constrictor response to Ang II in rat mesenteric resistance arteries (58). The discrepancy 
in these results may be due to differences in vessels studied. The present study 
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demonstrates that there is greater Ang II-induced vasoconstriction in arterioles from 
skeletal muscles of old rats (Figure 2.1).  
Musch et al. (75) reported that although total hindlimb muscle blood flow is not 
altered with advanced age during submaximal treadmill exercise in rats, blood flow to 
specific muscles or muscle parts are altered based on the oxidative potential of the 
muscle.  For example, perfusion of highly oxidative muscles (e.g., the soleus muscle) is 
lower during exercise in old rats, whereas blood flow to low oxidative muscles (e.g., the 
white portion of gastrocnemius muscle) is greater. Results from the present study 
showing enhanced Ang II-mediated vasoconstriction with old age in soleus muscle 
arterioles are consistent with the lower exercise hyperemia in the soleus muscle of aged 
rats.  However, data from gastrocnemius muscle arterioles showing enhanced Ang II-
mediated vasoconstriction appear to be at odds with the observation by Musch et al. (75) 
of a greater muscle perrfusion during exercise in this low oxidative muscle.  Two factors 
could serve to explain this apparent discrepancy.  First, several previous studies (6, 70, 
71, 98) as well as the present study (Table 2.2) report that the luminal diameter of feed 
arteries and arterioles are enlarged in the white portion of gastrocnemius muscle from 
old rats.  The increased size of the resistance vasculature in low oxidative muscles such 
as the white gastrocnemius muscle could contribute to the old age-related elevation in 
muscle blood flow during exercise despite a greater Ang II-induced vasoconstriction. A 
second potential factor contributing to the higher perfusion of low oxidative muscle is a 
change in the muscle recruitment pattern during exercise with aging. During moderate to 
high intensity treadmill running (20 m/min), the intensity of exercise used by Musch et 
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al. (75) to measure muscle blood flow in young and old rats, the muscles recruited in the 
young animals would predominantly be the high oxidative muscles, such as the soleus 
muscle, with little recruitment of low oxidative muscle (17, 59).  However, perfusion of 
the highly oxidative hindlimb muscles in the old rats is lower than that in the young 
animals (75).  The compromised delivery of oxygen to high oxidative muscle would 
likely cause premature fatigue of these muscles and necessitate the recruitment of other 
low oxidative muscles in order to maintain the exercise intensity imposed on the animals.  
Thus, the higher blood flow to low oxidative muscles in the older rats may more closely 
reflect a change in the motor unit recruitment pattern with age and consequently greater 
muscle activity and metabolism in the low oxidative muscle rather than a change in the 
vasomotor properties of the arterioles.   
2.4.3 Mechanisms for age-related increase in Ang II-induced vasoconstriction 
The present study indicates that the mechanisms for the age-associated alteration 
in Ang II-induced vasoconstriction is an endothelium-dependent mechanism, since aging 
differences were abolished with the removal of the endothelial cell layer (Figure 2.3). 
Previous studies have shown that aging-induced alterations in NE-mediated 
vasoconstrictor responses occur through an endothelium-dependent mechanism (27), 
whereas aging-induced enhancement of ET 1-mediated vasoconstriction is a smooth 
muscle cell-dependent mechanism through the ETa receptors (28). Results from the 
present study, as well as these of NE-mediated vasoconstriction (27), are consistent with 
previous studies reporting that endothelial vasodilator function declines with age (21, 71, 
118). Moreover, previous studies demonstrating Ang II-induced vasoconstriction has an 
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endothelium-dependent component supports the finding of this study. For example, 
Gruetter et al. (38) reported that malfunction of the endothelium significantly increases 
Ang II-induced contraction in rat aorta and bovine coronary artery, and Haberl et al. (40) 
suggested that Ang II produces a vasodilator factor from the endothelium in the rat 
cerebral arterioles. Therefore, dysfunction of endothelial cell signaling with aging can be 
an important mechanism to determine an age-associated enhancement of Ang II-
mediated vasoconstriction. 
As previously described, endothelium-dependent vasodilation is n aimportant 
factor in determining Ang II-induced vasoconstrictor responsiveness. Three pathways 
responsible for endothelium-dependent vasodilation are currently known: NO, which is 
released by action of NOS, prostacyclin (PGI2), which is formed through 
cyclooxygenase (COX), and endothelium-derived hyperpolarizing factor (EDHF).  The 
present results indicate that the NOS signaling pathway plays the major role in 
determining the age-associated alteration in Ang II-induced vasoconstriction, since this 
age-associated difference is eliminated with treatment of L-NAME in the arterioles from 
soleus (Figure 2.4 A) and gastrocnemius (Figure 2.4 B) muscles. Moreover, as illustrated 
in Figure 2.8, the effect of NOS blockade and effect of the removal of endothelium on 
Ang II-induced vasoconstrictions are comparable in arterioles from soleus (Figure 2.8 A) 
and gastrocnemius (Figure 2.8 B) muscles. These results suggest that NO is the major 
mechanism responsible for the endothelium-dependent vasodilator component of Ang II-
induced vasoconstriction in rat skeletal muscle arterioles. Although some studies have 
reported that Ang-II induced vasodilation through the endothelium is dependent on the 
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COX mechanism in rat cerebral arterioles (40) or, neither NOS nor COX (4), the 
preponderance of evidence demonstrates that Ang II-induced constriction is modulated 
by the release of endothelium-derived NO through endothelial AT1R in rat carotid artery 
(8) and cultured endothelial cell from rat aorta (87), and endothelial AT2R (65) in rat 
mesenteric resistance arteries and in rat aorta (116). Pueyo et al. (87) found that NO 
production in the endothelial cell is augmented by Ang II infusion and this increased NO 
production is abolished by losartan, an AT1R-specific antagonist. They also found that 
cyclic GMP levels are increased with Ang II infusion, but it is reduced with losartan. 
These data suggest that Ang II can elicit endothelium-dependent vasodilation by Ang II-
induced NO release and it may modulate the direct vasoconstrictor effects of Ang II on 
smooth muscle cells through increased cGMP production. Moreover, Ang II infusion 
with NG-monomethyl-L-arginine (L-NMMA), another NOS antagonist, results in less 
NO production and the treatment of L-NAME with Ang II decreases blood flow and 
vascular conductance (105).  
2.4.4 The effect of exercise training on Ang II-induced vasoconstriction 
Although several studies have been performed to investigate the effects of 
chronic exercise training on vasoconstrictor responsiveness to NE and ET-1 (20, 27, 99), 
no direct study elucidating the effect of endurance training on Ang II-induced 
vasoconstriction has been reported. It is believed that this present study is the first to 
examine the long-term exercise training effect on vasoconstrictor responsiveness to Ang 
II in rat skeletal muscle arterioles in young and old rats. Our results indicate that exercise 
training reduces Ang II-mediated vasoconstriction in arterioles from soleus and 
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gastrocnemius muscles of old rats, but has no effect on arterioles from young rats 
(Figure 2.5).  This present study is consistent with the study of Donato et al. (27) 
showing that the effect of exercise training on the NE-mediated vasomotor response 
occurs only in aged skeletal arterioles, whereas previous studies also reported that long-
term exercise training reduces NE-mediated vasoconstrictor responsiveness in 
abdominal aortas from young animals as well (20, 99). This discrepancy related to the 
effects of exercise training on NE-mediated vasoconstriction in young animals may be 
due to different adaptations to exercise in different vascular beds or differences in the 
type of artery studied, i.e., conduit arteries vs. resistance arterioles. It has shown that 
endurance training can increase leg blood flow in aged humans (22, 64, 106) and that the 
mechanism for this exercise training-induced increase in blood flow in the elderly is 
through endothelium-dependent vasodilation (19, 20, 22, 98, 106). Our results suggest 
that endurance exercise training can also ameliorate an age-associated enhancement of 
Ang II- induced vasoconstriction through an endothelium-dependent pathway, and that 
this may be one contributing mechanism to enhance blood flow in trained elderly 
individuals.  
2.4.5 The mechanism for exercise training-associated reduction in Ang II-induced 
vasoconstriction 
In addition, the present results suggest that the mechanism of this reduced Ang 
II-induced vasoconstriction in exercise trained arterioles from old skeletal muscle is the 
endothelium-dependent NOS signaling pathway (Figure 2.6 & Figure 2.7). It has been 
shown that activation of endothelial AT1R and AT2R results in the release of NO (8, 65, 
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87, 116) and PGI2 (40), which promote vasodilation in the blood vessel. The present 
study indicates that NO is fully responsible for the exercise training-associated reduction 
in Ang II-induced vasoconstriction in the rat skeletal muscle arterioles (Figure 2.9). 
Although no direct studies were performed to investigate the possible PGI2  and EDHF 
mechanisms on Ang II-induced vasoconstrictor responses, the notion that training 
primarily affects the endothelial NOS signaling pathway is supported by the finding of 
Spier et al. (98), who found that exercise training enhances the endothelium-mediated 
vasodilation via the NOS pathway in rat skeletal muscle arterioles from old rats.  
One of the mechanisms to improve vasodilator function by exercise training is 
increased eNOS mRNA and protein expression in the vascular endothelium through a 
vascular shear stress stimulus (98). Exposure of the endothelium to exercise-induced 
increases in Ang II concentration is another possible mechanism to increase eNOS 
expression in the endothelium. The plasma concentration of Ang II is increased during 
dynamic exercise, and there is a reported doubling during exercise at 80% of maximal 
heart rate (114). Also, it has been reported that Ang II increases eNOS mRNA and 
protein expression (43, 79).  Hennington et al. (43) found that acute Ang II-infusion (8 
ng/kg/min) for 110 minutes resulted in increased renal eNOS mRNA, but no change in 
renal eNOS protein concentration, whereas chronic Ang II-infusion (5 ng/kg/min) for 10 
days increased renal eNOS protein content, but no change in renal eNOS mRNA (43). 
Olson et al. (79) also found that in the bovine pulmonary artery endothelium that eNOS 
mRNA expression was increased 2.4-fold with 4 hours of 1µM Ang II infusion and 
eNOS protein content was elevated 3.3-fold with Ang II infusion for 8 hours. These data 
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suggest that chronic elevations in plasma Ang II concentration with dynamic exercise 
training could serve as a stimulus to increase levels of eNOS mRNA and protein in the 
endothelium. Consequently, there could be a greater vasodilator component to Ang II 
vasomotor responses in arterioles from exercise trained animals, resulting in a 
diminished net vasoconstrictor response. 
2.4.6 Conclusion and significance 
In conclusion, Ang II-induced vasoconstriction is determined by the net effects 
of a potent smooth muscle cell vasoconstrictor response and less potent endothelium-
dependent vasodilator influence via a NOS signaling pathway. With aging, Ang II-
mediated vasoconstriction is enhanced due to an age-associated dysfunction of the 
endothelium-dependent NOS vasodilator mechanism. Exercise training can ameliorate 
this age-associated enhancement of Ang II-induced vasoconstriction through an 
enhancement in the endothelium-dependent NOS signaling pathway.  
Although the majority of studies in the literature have focused on the role of Ang 
II in the regulation of renal and splanchnic blood flow, Ang II is also important for the 
regulation of skeletal muscle blood flow during exercise. Since aging can elevate the 
Ang II-induced vasoconstrictor responsiveness of skeletal muscle arterioles and exercise 
training can ameliorate this enhanced vasoconstriction to Ang II, these data in the 
present study suggest that the effects of aging and exercise training on skeletal muscles 
vasomotor responsiveness to Ang II may play a role in old age-associated reductions in 
skeletal muscle blood flow and the training-induced restoration of muscle perfusion 
during exercise. 
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CHAPTER III 
SUMMARY AND CONCLUSION 
 
 
The overall purpose of this dissertation research was to determine whether aging 
alters Ang II vasoreactivity of skeletal muscle resistance arterioles and whether exercise 
training can ameliorate possible alterations in Ang II-induced vasoconstriction. A 
secondary purpose was to elucidate the mechanism(s) of possible aging and exercise 
training effects on Ang II-induced vasoconstrictor responses of skeletal muscle 
resistance arterioles from old rats. We tested six hypotheses and found that: 
1) there was higher Ang II-induced vasoconstriction in arterioles from soleus and 
gastrocnemius muscles of old vs. young rats (Figure 2.1), 
2) removal of the endothelium abolished the age-associated difference of Ang II-
mediated vasoconstriction in soleus and gastrocnemius muscle arterioles 
(Figure 2.3), 
3) inhibition of NOS activity with L-NAME abolished the age-associated 
difference in Ang II-mediated vasoconstriction in soleus and gastrocnemius 
muscle arterioles (Figure 2.4), 
4) exercise training decreased Ang II-mediated vasoconstriction in aged arterioles 
from soleus and gastrocnemius muscles (Figure 2.5), 
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5) removal of the endothelium eliminated the exercise training-associated 
reduction in Ang II-mediated vasoconstriction in arterioles from soleus and 
gastrocnemius muscles of old rats (Figure 2.6), and 
6) inhibition of NOS activity with L-NAME eliminated the exercise training-
associated reduction of Ang II-mediated vasoconstriction in arterioles from 
both soleus and gastrocnemius muscles of aged rats (Figure 2.7). 
In conclusion, aging results in enhanced Ang II-mediated vasoconstriction in the 
arterioles from the rat skeletal muscle due to age-associated dysfunction of endothelium-
dependent NOS signaling pathway. However, exercise training could ameliorate this 
age-associated increase in Ang II-induced vasoconstriction in the arterioles from the rat 
skeletal muscle through an enhanced endothelium-dependent NOS signaling mechanism. 
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